about
Inhibition of phosphoinositol 3 kinase contributes to nanoparticle-mediated exaggeration of endotoxin-induced leukocyte procoagulant activityAmbiguities in applying traditional Limulus amebocyte lysate tests to quantify endotoxin in nanoparticle formulations.Biological assessment of triazine dendrimer: toxicological profiles, solution behavior, biodistribution, drug release and efficacy in a PEGylated, paclitaxel constructA novel nanoparticulate formulation of arsenic trioxide with enhanced therapeutic efficacy in a murine model of breast cancer.Fullerenol cytotoxicity in kidney cells is associated with cytoskeleton disruption, autophagic vacuole accumulation, and mitochondrial dysfunctionMembrane protein crystallization in meso: lipid type-tailoring of the cubic phaseInduction of oxidative stress by Taxol® vehicle Cremophor-EL triggers production of interleukin-8 by peripheral blood mononuclear cells through the mechanism not requiring de novo synthesis of mRNA.Common pitfalls in nanotechnology: lessons learned from NCI's Nanotechnology Characterization Laboratory.Induction of autophagy in porcine kidney cells by quantum dots: a common cellular response to nanomaterials?Detoxification of gold nanorods by treatment with polystyrenesulfonate.Choice of method for endotoxin detection depends on nanoformulation.Early Development Challenges for Drug Products Containing Nanomaterials.Zeta potential: a case study of cationic, anionic, and neutral liposomes.Controlling release from the lipidic cubic phase. Amino acids, peptides, proteins and nucleic acids.Analyzing the influence of PEG molecular weight on the separation of PEGylated gold nanoparticles by asymmetric-flow field-flow fractionation.Elemental Analysis in Biological Matrices Using ICP-MS.PEG Quantitation Using Reversed-Phase High-Performance Liquid Chromatography and Charged Aerosol Detection.Quantitation of Surface Coating on Nanoparticles Using Thermogravimetric Analysis.Rapid distribution of liposomal short-chain ceramide in vitro and in vivo.Quantitative analysis of PEG-functionalized colloidal gold nanoparticles using charged aerosol detection.Phase behavior of a monoacylglycerol: (myverol 18-99K)/water systemHER2-specific affibody-conjugated thermosensitive liposomes (Affisomes) for improved delivery of anticancer agentsRoom to move: crystallizing membrane proteins in swollen lipidic mesophasesTumor necrosis factor interaction with gold nanoparticlesSizing up the Next Generation of NanomedicinesTotal drug quantification in prodrugs using an automated elemental analyzer
P50
Q28386730-2BFB52A2-D9A7-4189-94A1-375E9B5FF563Q33975321-99C04AA4-EB2F-47B1-AF7D-2A24893C3D02Q34038519-1FF83F56-DA02-4E72-BF41-4FD9AA7DE1C4Q34145056-BD0AD101-6682-4C84-BEF9-64D168713346Q34172581-3318DAFE-4369-40AD-B023-1E6EBB5058B5Q34179475-D3E04361-CDF0-41B5-8C91-00B41E15F34AQ36297703-DD264F5B-D4EE-4740-A2D6-6392DFD794BBQ36403660-4725B5E8-F1D9-4FFD-8E52-668D19A84A6AQ36927008-E77BE086-683E-40EE-89D9-3670B7C70337Q37033845-7EABB3B6-DBF6-406B-8B35-6B6F3DDBF870Q39041437-C13C5FF0-1078-4F83-9722-24592295CAC5Q39405855-26731715-A0BB-49C1-912F-D916087297D0Q46327978-EBF4F2DF-0CC2-4B62-A87F-F7790C64B9D3Q46577085-F1ED0D46-D644-4D64-B7BC-47C9026CE819Q46657483-D7112186-59FB-4B25-8F41-E174AF1FA8CEQ48524098-701C8457-77CF-48DD-A6B2-78EA0F51538EQ50078004-D8C9C833-9FFA-4FAE-A07A-7C3A15F2706EQ50078011-10DF8F27-A52C-4ADF-83C9-2DAEDCB8CF98Q50648780-1FF85239-72C0-4732-B166-582FEDF9380EQ53591003-65F4B34C-AEEB-45C4-B828-8607649077ECQ73222305-84E0BE09-4D60-4E5B-A406-9CF28ACEA4EFQ79662028-591D75A1-761B-4F2E-80AE-8AC77B2D1154Q82611851-ACDA49A2-7B99-4F77-BA0D-7D1CB2FB12A1Q83823614-D44AE21B-FC47-4CDA-AA56-31E5D9172316Q91904781-B0A1EA89-DCCC-45AC-9D9F-E1D7C23D6F3DQ92232606-819E530F-D1C3-40CE-8767-CF5072C14752
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Jeffrey D Clogston
@ast
Jeffrey D Clogston
@en
Jeffrey D Clogston
@es
Jeffrey D Clogston
@nl
Jeffrey D Clogston
@sl
type
label
Jeffrey D Clogston
@ast
Jeffrey D Clogston
@en
Jeffrey D Clogston
@es
Jeffrey D Clogston
@nl
Jeffrey D Clogston
@sl
prefLabel
Jeffrey D Clogston
@ast
Jeffrey D Clogston
@en
Jeffrey D Clogston
@es
Jeffrey D Clogston
@nl
Jeffrey D Clogston
@sl
P106
P31
P496
0000-0003-1860-9271